Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
0.9958
-0.0042 (-0.42%)
Oct 8, 2026, 2:09 PM EDT - Market open
Ocugen Market Cap
Ocugen has a market cap or net worth of $337.69 million as of October 8, 2026. It is the 17,605th most valuable company in the world and the 3,094th biggest in the United States. Its market cap has decreased by 38.56% in one year.
Market Cap
337.69M
Enterprise Value
325.62M
1-Year Change
-38.56%
Global Rank
Country Rank
#3,094 United States
Category
ChartMarket Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $337.69M, an increase of 931.12%. That is a compound annual growth rate of 39.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 337.69M | -19.91% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 366.80M |
| Enanta Pharmaceuticals | 361.45M |
| Arcturus Therapeutics Holdings | 361.26M |
| Inhibikase Therapeutics | 360.51M |
| C4 Therapeutics | 353.08M |
| Relmada Therapeutics | 350.94M |
| Artiva Biotherapeutics | 348.59M |
| Orchestra BioMed Holdings | 345.24M |